Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord

Nguyen, S.; Achour, A.; Souchet, L.; Vigouroux, S.; Chevallier, P.; Furst, S.; Sirvent, A.; Bay, J.-O.; Socié, G.; Ceballos, P.; Huynh, A.; Cornillon, J.; Francois, S.; Legrand, F.; Yakoub-Agha, I.; Michel, G.; Maillard, N.; Margueritte, G.; Maury, S.; Uzunov, M.; Bulabois, C.-E.; Michallet, M.; Clement, L.; Dauriac, C.; Bilger, K.; Lejeune, J.; Béziat, V.; Rocha, V.; Rio, B.; Chevret, S.; Vieillard, V.

Published in

Springer Nature [academic journals on nature.com], Bone Marrow Transplantation, 10(52), p. 1428-1435, 2017

DOI: 10.1038/bmt.2017.122

Tools

Export citation

Search in Google Scholar

Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord

Journal article published in 2017 by S. Nguyen, A. Achour, L. Souchet, S. Vigouroux, P. Chevallier, S. Furst, A. Sirvent, J.-O. Bay, G. Socié, P. Ceballos, A. Huynh, J. Cornillon, S. Francois, F. Legrand, I. Yakoub-Agha and other authors.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools